PLX PHARMA INC - COM (PLXPQ)

CUSIP: 72942A107

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM
Total 13F shares
2,120,416
Share change
+65,931
Total reported value
$11,704,000
Price per share
$5.52
Number of holders
15
Value change
+$444,322
Number of buys
5
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 72942A107?
CUSIP 72942A107 identifies PLXPQ - PLX PHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PLX PHARMA INC - COM (PLXPQ) as of Q4 2020

As of 31 Dec 2020, PLX PHARMA INC - COM (PLXPQ) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,120,416 shares. The largest 10 holders included Park West Asset Management LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO, Heritage Way Advisors, LLC, 683 Capital Management, LLC, CREDIT SUISSE AG/, MILLENNIUM MANAGEMENT LLC, Fayez Sarofim & Co, and NORTHERN TRUST CORP. This page lists 15 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.